cryptolepine has been researched along with Liver Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansah, C; Awandare, GA; Domfeh, SA; Kusi, KA; Mutocheluh, M; Narkwa, PW; Quaye, O; Salam, A | 1 |
1 other study(ies) available for cryptolepine and Liver Neoplasms
| Article | Year |
|---|---|
Cryptolepine inhibits hepatocellular carcinoma growth through inhibiting interleukin-6/STAT3 signalling.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cryptolepis; Hep G2 Cells; Humans; Indole Alkaloids; Interleukin-6; Liver Neoplasms; Quinolines; Signal Transduction; STAT3 Transcription Factor | 2021 |